RAMM Pharma Corp.
RAMM
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.13M | -12.11M | -6.54M | -6.59M | -6.18M |
| Total Depreciation and Amortization | 826.10K | 887.00K | 847.90K | 885.70K | 975.00K |
| Total Amortization of Deferred Charges | 400.00 | 0.00 | 300.00 | -- | -- |
| Total Other Non-Cash Items | 6.60M | 7.20M | 2.28M | 2.23M | 2.22M |
| Change in Net Operating Assets | 1.47M | 1.08M | -63.60K | 356.30K | -284.20K |
| Cash from Operations | -2.24M | -2.94M | -3.47M | -3.12M | -3.26M |
| Capital Expenditure | -42.80K | -34.80K | -57.40K | -48.30K | -50.40K |
| Sale of Property, Plant, and Equipment | -- | -- | 103.00K | 103.00K | 79.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.50K | 300.00 | 27.10K | 55.90K | 55.30K |
| Cash from Investing | -84.20K | -34.40K | 72.80K | 110.70K | 84.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -264.80K | -258.10K | -265.10K | -253.90K | -254.90K |
| Issuance of Common Stock | -- | -- | 1.50K | 1.50K | 1.50K |
| Repurchase of Common Stock | -- | -- | -- | -120.70K | -120.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 8.50K | 4.60K | 100.00 |
| Cash from Financing | -192.30K | -189.70K | -187.80K | -274.00K | -278.20K |
| Foreign Exchange rate Adjustments | 21.10K | 500.00 | 20.20K | 10.40K | -600.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.49M | -3.16M | -3.57M | -3.27M | -3.46M |